A number of relatively new antimicrobial agents have been evaluated for use in skin and soft tissue infections, and their results have been reported in the last year. The importance of a favorable agent is significant to the clinician when faced with the ever-increasing number of immunocompromised patients, patients with unusual infections, and patients with infections caused by organisms resistant to first-line therapy. Infection control in the hospital has improved greatly with regard to reducing nosocomial infections through careful skin hygiene. This review introduces the reader to some new developments and antimicrobial indicatiosn in skin and soft tissue infections.
© Lippincott-Raven Publishers.